DE69229057T2 - 1-(arylalkyl-aminoalkyl) imidazolderivate, herstellungs verfahren und verwendung als therapeutische mittel - Google Patents

1-(arylalkyl-aminoalkyl) imidazolderivate, herstellungs verfahren und verwendung als therapeutische mittel

Info

Publication number
DE69229057T2
DE69229057T2 DE69229057T DE69229057T DE69229057T2 DE 69229057 T2 DE69229057 T2 DE 69229057T2 DE 69229057 T DE69229057 T DE 69229057T DE 69229057 T DE69229057 T DE 69229057T DE 69229057 T2 DE69229057 T2 DE 69229057T2
Authority
DE
Germany
Prior art keywords
alkyl
phenyl
pct
alkoxy
alkoxycarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69229057T
Other languages
English (en)
Other versions
DE69229057D1 (de
Inventor
Lawrence Clegg
Ian Hunneyball
Colin Jones
Paul The Boots Compan Rafferty
Leslie The Boots Compan Steele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
British Technology Group Inter Corporate Licensing Ltd
Original Assignee
British Technology Group Inter Corporate Licensing Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Inter Corporate Licensing Ltd filed Critical British Technology Group Inter Corporate Licensing Ltd
Application granted granted Critical
Publication of DE69229057D1 publication Critical patent/DE69229057D1/de
Publication of DE69229057T2 publication Critical patent/DE69229057T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
DE69229057T 1991-12-23 1992-12-12 1-(arylalkyl-aminoalkyl) imidazolderivate, herstellungs verfahren und verwendung als therapeutische mittel Expired - Fee Related DE69229057T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919127304A GB9127304D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
PCT/EP1992/002899 WO1993013075A1 (en) 1991-12-23 1992-12-12 1-(arylalkyl-aminoalkyl)imidazole derivatives, processes of preparation and use as therapeutical agents
CN93107988A CN1037511C (zh) 1991-12-23 1993-06-22 1－(芳烷基－氨烷基)咪唑化合物的制备方法

Publications (2)

Publication Number Publication Date
DE69229057D1 DE69229057D1 (de) 1999-06-02
DE69229057T2 true DE69229057T2 (de) 1999-10-21

Family

ID=36822309

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229057T Expired - Fee Related DE69229057T2 (de) 1991-12-23 1992-12-12 1-(arylalkyl-aminoalkyl) imidazolderivate, herstellungs verfahren und verwendung als therapeutische mittel

Country Status (29)

Country Link
US (1) US5547972A (de)
EP (1) EP0618907B1 (de)
JP (1) JP2633087B2 (de)
CN (1) CN1037511C (de)
AT (1) ATE179416T1 (de)
AU (1) AU656839B2 (de)
BG (1) BG98812A (de)
CA (1) CA2126177A1 (de)
CZ (1) CZ153394A3 (de)
DE (1) DE69229057T2 (de)
ES (1) ES2131574T3 (de)
FI (1) FI943020A0 (de)
GB (1) GB9127304D0 (de)
HR (1) HRP921457A2 (de)
HU (2) HUT67372A (de)
IL (1) IL104168A (de)
IN (1) IN174436B (de)
MX (1) MX9207491A (de)
NO (1) NO304373B1 (de)
NZ (1) NZ246336A (de)
PH (1) PH30660A (de)
PL (1) PL172497B1 (de)
RO (1) RO113985B1 (de)
RU (1) RU2118957C1 (de)
SI (1) SI9200411A (de)
SK (1) SK75294A3 (de)
WO (1) WO1993013075A1 (de)
YU (1) YU48294B (de)
ZA (1) ZA929914B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312893D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
US5741800A (en) * 1993-06-22 1998-04-21 Knoll Aktiengesellachaft Azolyl-cyclic amine derivates with immunomodulatory activity
WO1995022327A1 (en) * 1994-02-22 1995-08-24 Knoll Ag Use of 1-(arylalkylaminoalkyl) imidazoles for treating neurological damage
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
US5700825A (en) * 1995-03-31 1997-12-23 Florida State University Radiosensitizing diamines and their pharmaceutical preparations
US5710171A (en) * 1995-05-24 1998-01-20 Merck & Co., Inc. Bisphenyl inhibitors of farnesyl-protein transferase
US6063930A (en) * 1996-04-03 2000-05-16 Merck & Co., Inc. Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
US6080870A (en) * 1996-04-03 2000-06-27 Merck & Co., Inc. Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
US6358060B2 (en) * 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
DE19850301A1 (de) * 1998-10-30 2000-05-04 Basf Ag Verfahren zur Racematspaltung von 2-Hydroxypropionsäuren
EP1741709A1 (de) 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl substituierte Amide mit gesättigtem Linker, und deren Verwendung als Pharmaka
US8642016B2 (en) * 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
WO2016126957A1 (en) * 2015-02-04 2016-08-11 The Board Of Trustees Of The University Of Alabama Gas treating solutions containing imidazole-amine compounds

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
GB1341375A (en) * 1969-11-19 1973-12-19 Smith Kline French Lab Aminoalkylimidazoles and process for their production
DE2107487A1 (de) * 1970-02-26 1971-09-09 CIBA Geigy AG, Basel (Schweiz) Neue Amine und Verfahren zu ihrer Herstellung
DE2041771C3 (de) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivate
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
DE2862340D1 (en) * 1978-02-01 1983-11-24 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
US4338453A (en) * 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4404387A (en) * 1980-09-17 1983-09-13 The Upjohn Company Aminoalkyl-substituted imidazoles
JPS5769089A (en) * 1980-10-17 1982-04-27 Fuji Photo Film Co Ltd Desensitizer composition
DK162882A (da) * 1981-04-13 1982-10-14 Searle & Co Imidazolderivater eller syreadditionssalte deraf,deres fremstilling og anvendelse
GB2110663B (en) * 1981-12-04 1985-08-07 Farmos Group Ltd Imidazole derivatives
DE3369984D1 (en) * 1982-07-12 1987-04-09 Searle & Co 1-(1h-imidazolyl), 1-n-morpholinyl and pyridyl compounds, their preparation and pharmaceutical compositions containing them
DE3238006A1 (de) * 1982-10-13 1984-04-19 Bayer Ag, 5090 Leverkusen Azolyl-methylamine, ihre herstellung und verwendung in mikrobiziden mitteln
EP0117462A3 (de) * 1983-02-28 1986-08-20 American Cyanamid Company N-(2-4-(1H-Imidazol-1-yl)alkyl)arylamide
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
GB8412750D0 (en) * 1984-05-18 1984-06-27 Ici Plc Heterocyclic compounds
US4728663A (en) * 1986-01-13 1988-03-01 American Cyanamid Company N-[(1H-imidazol-1-yl)alkyl]benz[cd]-indol-2-amines and use in inhibiting thromboxane synthetase enzyme
JPH0774205B2 (ja) * 1986-12-04 1995-08-09 三井石油化学工業株式会社 新規イミダゾ−ル誘導体
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
KR920701167A (ko) * 1989-07-07 1992-08-11 에릭 에스. 딕커 약제학적 활성 화합물
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
EP0485890A3 (en) * 1990-11-16 1992-07-08 Hoechst Aktiengesellschaft Use of 2,3-disubstituate 1-azolyl-propane for inhibiting the pathogenic growth phase of dimorph yeast cell
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.

Also Published As

Publication number Publication date
HU9401453D0 (en) 1994-08-29
JPH07502519A (ja) 1995-03-16
IL104168A0 (en) 1993-05-13
EP0618907B1 (de) 1999-04-28
HUT67372A (en) 1995-03-28
SK75294A3 (en) 1995-04-12
AU3256393A (en) 1993-07-28
IN174436B (de) 1994-12-03
JP2633087B2 (ja) 1997-07-23
CA2126177A1 (en) 1993-07-08
MX9207491A (es) 1993-07-01
PL172497B1 (pl) 1997-09-30
NO942374D0 (de) 1994-06-22
EP0618907A1 (de) 1994-10-12
NZ246336A (en) 1995-12-21
RU94030470A (ru) 1997-04-27
YU48294B (sh) 1998-05-15
YU110592A (sh) 1996-01-08
GB9127304D0 (en) 1992-02-19
NO942374L (no) 1994-06-22
CN1096781A (zh) 1994-12-28
BG98812A (bg) 1995-05-31
ES2131574T3 (es) 1999-08-01
RO113985B1 (ro) 1998-12-30
SI9200411A (en) 1993-09-30
DE69229057D1 (de) 1999-06-02
FI943020A (fi) 1994-06-22
PH30660A (en) 1997-09-16
RU2118957C1 (ru) 1998-09-20
HRP921457A2 (en) 1996-02-29
FI943020A0 (fi) 1994-06-22
CZ153394A3 (en) 1995-10-18
US5547972A (en) 1996-08-20
WO1993013075A1 (en) 1993-07-08
HU211598A9 (en) 1995-12-28
NO304373B1 (no) 1998-12-07
ATE179416T1 (de) 1999-05-15
AU656839B2 (en) 1995-02-16
CN1037511C (zh) 1998-02-25
ZA929914B (en) 1993-06-23
IL104168A (en) 1999-04-11

Similar Documents

Publication Publication Date Title
ATE179416T1 (de) 1-(arylalkyl-aminoalkyl) imidazolderivate, herstellungs verfahren und verwendung als therapeutische mittel
ES512842A0 (es) "procedimiento de preparar derivados carboxamidicos".
FR2698873B1 (fr) Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
ATE196293T1 (de) Triazole enthaltende antifungizide mittel
HUT37751A (en) Process for production of new, substituated prrolidinons
DE69029861D1 (de) N-acyl-substituierte azazyklische verbindungen, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE278676T1 (de) Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren
JO1755B1 (en) Therapeutic agents
MY107787A (en) Therapeutic agents
DK0832079T3 (da) Antiiskæmiske hydroxylaminderivater og farmaceutiske sammensætninger
FR2695643B1 (fr) Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant.
JO1825B1 (en) Therapeutic agents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee